Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Telmisartan + Lacidipine in Healthy Males
NCT02218684Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 1998
- Primary completion
- Nov 1998
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of telmisartan and lacidipine in hypertension (HTN) (4 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Maximum measured concentration of the analyte in plasma up to 72 hours and Number of subjects with adverse events up to 72 hours. Started Sep 1998; status: completed.
02
Drugs
telmisartanlacidipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02218684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02218684.